Mostafa Ejtehadifar

Dr. Mostafa Ejtehadifar

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
MEMostafa Ejtehadifar
Mostafa Ejtehadifar
KSKarim Shamsasenjan
Karim Shamsasenjan
AMAliakbar Movassaghpour
Aliakbar Movassaghpour
PAParvin Akbarzadehlaleh
Parvin Akbarzadehlaleh
NDNima Dehdilani
Nima Dehdilani
MSMahshid Saleh
Mahshid Saleh
The Effect of Hypoxia on Mesenchymal Stem Cell Biology

18 March 2017 in International Journal of Basic Science in Medicine
Verified
Journal Article
Open access
NMNada Molaae
Nada Molaae
GMGhasem Mosayebi
Ghasem Mosayebi
APAbbas Pishdadian
Abbas Pishdadian
MEMostafa Ejtehadifar
Mostafa Ejtehadifar
AGAli Ganji
Ali Ganji
Introduction: 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay is a safe, convenient, and low-cost technique with high applications for the measurement of cell proliferation rate in researches and clinical laboratories. Our aim was to evaluate the proliferation rate of human peripheral blood mononuclear cells (PBMCs) and production rate of Tumor necrosis factor alpha (TNF-α) by these cells after various mitogens stimulation in different situations. Methods: The MTT test was performed with various concentrations of mitogens including concanavalin A (ConA), lipopolysaccharide (LPS) and phytohemagglutinin (PHA) on the PBMCs. The cells were incubated for 24, 48, 72, and 96 hours in the culture medium and TNF-α cytokine assay was performed on the supernatant of the cultured splenocytes using the enzyme-linked immunosorbent assay (ELISA) method. Results: The optimal time and incubation of the PBMCs with the mixture of PHA-ConA were 5 μg/mL and 72 hours, respectively. The TNF-α level increased significantly after PHA-ConA and PHA stimulation. Conclusion: The results showed that the mixture of PHA-ConA (at the concentration of 5 μg/mL) can give rise to the optimal results on stimulation of the PBMcs using the MTT assay after 72 hours incubation.

Verified
Journal Article
Open access
PDF file
ACAna Sofia Carvalho
Ana Sofia Carvalho
HBHenrique Baeta
Henrique Baeta
AHAndreia Almeida Henriques
Andreia Almeida Henriques
MEMostafa Ejtehadifar
Mostafa Ejtehadifar
Erin TranfieldErin Tranfield
Erin Tranfield
Rune MatthiesenRune Matthiesen
Rune Matthiesen
The role of extracellular vesicles (EVs) proteome in diffuse large B-cell lymphoma (DLBCL) pathology, subclassification, and patient screening is unexplored. We analyzed by state-of-the-art mass spectrometry the whole cell and secreted extracellular vesicles (EVs) proteomes of different molecular subtypes of DLBCL, germinal center B cell (GCB subtype), and activated B cell (ABC subtype). After quality control assessment, we compared whole-cell and secreted EVs proteomes of the two cell-of-origin (COO) categories, GCB and ABC subtypes, resulting in 288/1115 significantly differential expressed proteins from the whole-cell proteome and 228/608 proteins from EVs (adjust p-value < 0.05/p-value < 0.05). In our preclinical model system, we demonstrated that the EV proteome and the whole-cell proteome possess the capacity to separate cell lines into ABC and GCB subtypes. KEGG functional analysis and GO enrichment analysis for cellular component, molecular function, and biological process of differential expressed proteins (DEP) between ABC and GCB EVs showed a significant enrichment of pathways involved in immune response function. Other enriched functional categories for DEPs constitute cellular signaling and intracellular trafficking such as B-cell receptor (BCR), Fc_gamma R-mediated phagocytosis, ErbB signaling, and endocytosis. Our results suggest EVs can be explored as a tool for patient diagnosis, follow-up, and disease monitoring. Finally, this study proposes novel drug targets based on highly expressed proteins, for which antitumor drugs are available suggesting potential combinatorial therapies for aggressive forms of DLBCL. Data are available via ProteomeXchange with identifier PXD028267.

10 September 2017 in Nutritional Neuroscience
Verified
Journal Article
Closed access
AGAli Ganji
Ali Ganji
IFIman Farahani
Iman Farahani
MPMohammad Reza Palizvan
Mohammad Reza Palizvan
AGAli Ghazavi
Ali Ghazavi
MEMostafa Ejtehadifar
Mostafa Ejtehadifar
GMGhasem Mosayebi
Ghasem Mosayebi
Objectives: Therapeutic approaches for multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS), are accompanied by various undesirable side effects. Owing to the anti-inflammatory and antioxidant effects of walnut, we investigated its effects on the experimental autoimmune encephalomyelitis (EAE) mouse model of MS. Methods: After EAE induction in mice, the treated group was gavaged daily with walnut oil. The weights and clinical symptoms were monitored daily for 21 days following the onset of symptoms. The spleens and brains of the mouse were removed and used for ELISA and histological studies. Results: The average disease severity and plaque formation in the brains of the walnut oil-treated group were significantly lower (P < 0.05) than those of the untreated group. Stimulated splenocytes of the treated group expressed significantly less INF-γ and interleukin (IL)-17 than the untreated group with no significant differences in IL-10 or IL-5 production. In serum from the treated group, IL-17 expression was also significantly less than in the untreated group, while IL-10 was greater (P < 0.05). Conclusion: Walnut oil significantly reduced disease severity, inhibited plaque formation, and altered cytokine production. More studies are required to identify the mechanism of action of walnut oil as a valuable supplement in the treatment of MS.

8 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SZSara Zahedi
Sara Zahedi
ACAna Sofia Carvalho
Ana Sofia Carvalho
MEMostafa Ejtehadifar
Mostafa Ejtehadifar
HBHans Christian Beck
Hans Christian Beck
NRNádia Rei
Nádia Rei
Rune MatthiesenRune Matthiesen
Rune Matthiesen
Background: Pleural effusion (PE) is common in advanced-stage lung cancer patients and is related to poor prognosis. Identification of cancer cells is the standard method for the diagnosis of a malignant PE (MPE). However, it only has moderate sensitivity. Thus, more sensitive diagnostic tools are urgently needed. Methods: The present study aimed to discover potential protein targets to distinguish malignant pleural effusion (MPE) from other non-malignant pathologies. We have collected PE from 97 patients to explore PE proteomes by applying state-of-the-art liquid chromatography-mass spectrometry (LC-MS) to identify potential biomarkers that correlate with immunohistochemistry assessment of tumor biopsy or with survival data. Functional analyses were performed to elucidate functional differences in PE proteins in malignant and benign samples. Results were integrated into a clinical risk prediction model to identify likely malignant cases. Sensitivity, specificity, and negative predictive value were calculated. Results: In total, 1689 individual proteins were identified by MS-based proteomics analysis of the 97 PE samples, of which 35 were diagnosed as malignant. A comparison between MPE and benign PE (BPE) identified 58 differential regulated proteins after correction of the p-values for multiple testing. Furthermore, functional analysis revealed an up-regulation of matrix intermediate filaments and cellular movement-related proteins. Additionally, gene ontology analysis identified the involvement of metabolic pathways such as glycolysis/gluconeogenesis, pyruvate metabolism and cysteine and methionine metabolism. Conclusion: This study demonstrated a partial least squares regression model with an area under the curve of 98 and an accuracy of 0.92 when evaluated on the holdout test data set. Furthermore, highly significant survival markers were identified (e.g., PSME1 with a log-rank of 1.68 × 10−6).

22 December 2016 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
MEMostafa Ejtehadifar
Mostafa Ejtehadifar
KSKarim Shamsasenjan
Karim Shamsasenjan
PAParvin Akbarzadehlaleh
Parvin Akbarzadehlaleh
SZSarah Zahedi
Sarah Zahedi
NKNarjes Kazemi
Narjes Kazemi
The Effects of Hypoxia on U937 Cell Line in Mesenchymal Stem Cells Co-Culture System